Chargement en cours...
BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma
Approximately, 50% of human melanomas are driven by BRAF mutations, which produce tumors that are highly immunosuppressive and often resistant to vaccine therapy. We introduced lipid-coated calcium phosphate nanoparticles (LCP NPs) as a carrier to efficiently deliver a tumor-specific antigen, the BR...
Enregistré dans:
| Publié dans: | Cancer Immunol Immunother |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Berlin Heidelberg
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5801101/ https://ncbi.nlm.nih.gov/pubmed/29094184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-017-2079-7 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|